XLCART001

· The First Affiliated Hospital with Nanjing Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XLCART001, covering 2019-08-07 to 2019-08-07. Get the full timeline:

Most recent: Clinical Trial Update: XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects [Phase 2]